Chronic Myeloid Leukemia Face-Off: Memorial Sloan Kettering vs Dana-Farber - Episode 5

Asciminib vs Bosutinib in Chronic Myeloid Leukemia Treatment

Daniel DeAngelo, MD, PhD, presents data from a phase 3 study comparing asciminib and bosutinib after treatment with 2 or more prior TKIs in CML.